B Cell Kinetics upon Therapy Commencement for Active Extrarenal Systemic Lupus Erythematosus in Relation to Development of Renal Flares: Results from Three Phase III Clinical Trials of Belimumab
Renal flares constitute major determinants of poor prognosis in people living with systemic lupus erythematosus (SLE). The aim of the present study was to investigate changes in B cell subsets in relation to renal flares upon initiation of standard therapy (ST) plus belimumab or placebo in patients...
Main Authors: | Ioannis Parodis, Alvaro Gomez, Julius Lindblom, Jun Weng Chow, Christopher Sjöwall, Savino Sciascia, Mariele Gatto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/22/13941 |
Similar Items
-
Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review
by: Noémie Gensous, et al.
Published: (2017-10-01) -
The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany
by: Bo Ding, et al.
Published: (2024-01-01) -
Case report: Severe sinus tachycardia as a leading manifestation of systemic lupus erythematosus flare
by: Anas A. Ashour, et al.
Published: (2023-10-01) -
Systemic lupus erythematosus flare up as acute spinal subarachnoid hemorrhage with bilateral lower limb paralysis
by: Xiang Yang, et al.
Published: (2018-05-01) -
LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab
by: Brad Rovin, et al.
Published: (2023-07-01)